Gilead Sciences funds competitive, high-quality clinical and translational oncology research to advance science and improve patient outcomes, with new opportunities announced periodically.
Funder: Gilead Sciences
Due Dates: No current deadlines (rolling submission; monitor for future RFPs)
Funding Amounts: Not specified; varies by RFP and project scope
Summary: Supports high-quality oncology research through competitive RFPs and topics of interest to advance clinical practice and patient outcomes.
Key Information: No open oncology RFPs at this time; check program page for updates.
Gilead Sciences provides research funding in oncology through Request for Proposal (RFP) Programs and RFP Topics of Interest. These initiatives are designed to foster impactful, high-quality clinical and translational research that can inform clinical decision-making and ultimately improve patient outcomes. While there are currently no open oncology RFPs, the program periodically announces new opportunities aligned with Gilead’s research priorities in solid tumors and related oncology fields.